Safety of Furosemide in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Randomized Controlled Trial
Saturday, April 23, 2022
1:15 PM – 1:30 PM US MT
Location: Convention Center: Mile High Ballroom 3AB
CE: Enduring CME: 0.25
Publication Number: 1545.2
Rachel G. Greenberg, Duke Clinical Research Institute, Durham, NC, United States; Jason E. Lang, Duke University School of Medicine, CHAPEL HILL, NC, United States; Brian Smith, Duke University School of Medicine, Durham, NC, United States; Prem S. Shekhawat, MetroHealth Hospital, Case Western Reserve University, Cleveland, OH, United States; Sherry Courtney, University of Arkansas for Medical Sciences, Little Rock, AR, United States; Mark L. Hudak, University of Florida College of Medicine - Jacksonville, Jacksonville, FL, United States; Fernando Moya, UNC Chapel Hill, Wilmington, NC, United States; Alaa Eldemerdash, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, United States; Barry T. Bloom, University of Kansas School of Medicine- Wichita, Wichita, KS, United States; Mitzi Donabel A. Go, Oregon Health & Science University, Portland, OR, United States; Mina Hanna, University of Kentucky College of Medicine, Lexington, KY, United States; Lawrence Rhein, University of Massachusetts Medical School, Waban, MA, United States; Sofia Aliaga, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States; Tamorah Lewis, Children’s Mercy Hospital, Toronto, ON, Canada; Aprille Dawn F. Febre, Loma Linda University Children's Hospital, Loma Linda, CA, United States; Autumn Kiefer, West Virginia University School of Medicine, Morgantown, WV, United States; Varsha Bhatt-Mehta, FDA, Ann Arbor, MI, United States; Joseph A. Khoury, Virginia Commonwealth University School of Medicine, Chesterfield, VA, United States; Ravinder Anand, The Emmes Company, LLC, Potomac, MD, United States; Kanecia O. Zimmerman, Duke Clinical Research Institute, Durham, NC, United States; Daniel Benjamin, Duke University School of Medicine, Durham, NC, United States; Matthew Laughon, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
Presenting Author(s)
Rachel G. Greenberg, MD, MB, MHS
Associate Professor Duke Clinical Research Institute Durham, North Carolina, United States
Jason E. Lang, Lang, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Brian Smith, MD MPH MHS: ● Nestle (Ended In the Past 24 Months) (Products/Services: Consultant). ● SPARC Pharma (Ended In the Past 24 Months) (Products/Services: Consultant). ● Tellus (Currently Ongoing) (Products/Services: Consultant). ● UCB (Currently Ongoing) (Products/Services: Consultant).
Prem S. Shekhawat, SHEKHAWAT, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sherry Courtney, MD MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mark L. Hudak, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Fernando Moya, MD: ● Mead Johnson NUtrition (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator, Speaker Honorarium including speakers bureau, symposia, and expert witness).
Alaa Eldemerdash, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Barry T. Bloom, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mitzi Donabel A. Go, MD, MCR: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mina Hanna, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Lawrence Rhein, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sofia Aliaga, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tamorah Lewis, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Aprille Dawn F. Febre, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Autumn Kiefer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Varsha Bhatt-Mehta, Pharm.D., MS (CRDSA): I do not have any relevant financial / non-financial relationships with any proprietary interests.
Joseph A. Khoury, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ravinder Anand, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kanecia O. Zimmerman, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Daniel Benjamin, Jr., MD PhD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Matthew Laughon, MD, MPH: ● Bayer (Ended In the Past 24 Months) (Products/Services: Consultant). ● I-ACT (Currently Ongoing) (Products/Services: Consultant).
